<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1400" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1400/" /><meta name="ncbi_pagename" content="Cystinosis - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Cystinosis - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Cystinosis" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/12/07" /><meta name="citation_author" content="Galina Nesterova" /><meta name="citation_author" content="William A Gahl" /><meta name="citation_pmid" content="20301574" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1400/" /><meta name="citation_keywords" content="Non-Nephropathic Cystinosis" /><meta name="citation_keywords" content="Intermediate Cystinosis" /><meta name="citation_keywords" content="Nephropathic Cystinosis" /><meta name="citation_keywords" content="Cystinosin" /><meta name="citation_keywords" content="CTNS" /><meta name="citation_keywords" content="Cystinosis" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Cystinosis" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Galina Nesterova" /><meta name="DC.Contributor" content="William A Gahl" /><meta name="DC.Date" content="2017/12/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1400/" /><meta name="description" content="Cystinosis comprises three allelic phenotypes:" /><meta name="og:title" content="Cystinosis" /><meta name="og:type" content="book" /><meta name="og:description" content="Cystinosis comprises three allelic phenotypes:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1400/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/ctns/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1400/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE893893E040873100000000048A01E9.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1400_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1400_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cf/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/abs/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1400_"><span class="title" itemprop="name">Cystinosis</span></h1><p class="contrib-group"><span itemprop="author">Galina Nesterova</span>, MD and <span itemprop="author">William A Gahl</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1400_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1400_ai__"><div class="contrib half_rhythm"><span itemprop="author">Galina Nesterova</span>, MD<div class="affiliation small">Clinical Center<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@gavoretsen" class="oemail">vog.hin.liam@gavoretsen</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">William A Gahl</span>, MD, PhD<div class="affiliation small">Clinical Director, National Human Genome<br />Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.xileh@lhagb" class="oemail">vog.hin.xileh@lhagb</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">March 22, 2001</span>; Last Revision: <span itemprop="dateModified">December 7, 2017</span>.</p><p><em>Estimated reading time: 29 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ctns.Summary" itemprop="description"><h2 id="_ctns_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Cystinosis comprises three allelic phenotypes:</p><ul><li class="half_rhythm"><div>Nephropathic cystinosis in untreated children is characterized by renal Fanconi syndrome, poor growth, hypophosphatemic/calcipenic rickets, impaired glomerular function resulting in complete glomerular failure, and accumulation of cystine in almost all cells, leading to cellular dysfunction with tissue and organ impairment. The typical untreated child has short stature, rickets, and photophobia. Failure to thrive is generally noticed after approximately age six months; signs of renal tubular Fanconi syndrome (polyuria, polydipsia, dehydration, and acidosis) appear as early as age six months; corneal crystals can be present before age one year and are always present after age 16 months. Prior to the use of renal transplantation and cystine-depleting therapy, the life span in nephropathic cystinosis was no longer than ten years. With these interventions, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals can survive at least into the mid-forties or fifties with satisfactory quality of life.</div></li><li class="half_rhythm"><div>Intermediate cystinosis is characterized by all the typical manifestations of nephropathic cystinosis, but onset is at a later age. Renal glomerular failure occurs in all untreated <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, usually between ages 15 and 25 years.</div></li><li class="half_rhythm"><div>The non-nephropathic (ocular) form of cystinosis is characterized clinically only by photophobia resulting from corneal cystine crystal accumulation.</div></li></ul></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of cystinosis is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by one of the following:</p><ul><li class="half_rhythm"><div>Identification of cystine crystals in the cornea on slit lamp examination</div></li><li class="half_rhythm"><div>Identification of elevated cystine concentration in polymorphonuclear leukocytes</div></li><li class="half_rhythm"><div>Demonstration of increased cystine content in cultured fibroblasts or in the placenta at the time of birth</div></li><li class="half_rhythm"><div>Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CTNS</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a></div></li></ul></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Renal Fanconi syndrome is treated by replacement of tubular losses of electrolytes, bicarbonate, minerals, and other small molecular weight nutrients; children should have free access to water and bathroom privileges and supplementation with citrate to alkalinize the blood; phosphate replacement and vitamin D supplements are also used to prevent and treat rickets; skeletal deformities should be addressed early with the help of orthopedic specialists. Fluid and nutrient replacement is required during episodes of dehydration. For renal glomerular disease, oral cysteamine reduces cellular cystine; renal transplantation provides the ultimate treatment. Cysteamine eye drops relieve photophobia. Nutrition must be adequate to minimize failure to thrive in infants. Growth hormone replacement, L-thyroxine for hypothyroidism, insulin for diabetes mellitus, and testosterone for hypogonadism in males are all beneficial. Physical and speech therapy is helpful for the muscle deterioration and swallowing difficulties of older individuals.</p><p><i>Prevention of primary manifestations:</i> Therapy with cystine-depleting agents begun as soon as the diagnosis is made or (if possible) shortly after birth will significantly slow the progression of glomerular damage; renal damage present at the time of diagnosis is irreversible. With optimal symptomatic and cystine-depleting therapy <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals grow at a normal rate but generally do not recover lost height unless human growth hormone is administered.</p><p><i>Prevention of secondary complications</i>: Those who have undergone renal transplantation should be monitored for signs of immunodeficiency and infection; carnitine supplementation administered pre-transplant may improve muscle strength; treatment with proton pump inhibitors helps relieve cysteamine-induced gastric acid hypersecretion.</p><p><i>Surveillance:</i> Evaluation by a nephrologist every three to six months depending on the severity of renal impairment; ophthalmologic evaluation every one to two years; assessment of bone mineralization throughout the disease course; fasting blood glucose concentration and testosterone concentration every two to three years (in males, starting before puberty); monitoring for late-onset complications by a multidisciplinary medical team.</p><p><i>Agents/circumstances to avoid:</i> Dehydration; sun exposure if photophobia is present.</p><p><i>Evaluation of relatives at risk:</i> Biochemical and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (if the genetic status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is known) allows for early diagnosis and treatment.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Cystinosis is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible if both pathogenic variants have been identified in the family. For pregnancies at increased risk for nephropathic cystinosis, prenatal diagnosis is also possible biochemically, based on elevated cystine concentrations in both chorionic villi and amniocytes.</p></div></div><div id="ctns.GeneReview_Scope"><h2 id="_ctns_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="ctns.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1400/table/ctns.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ctns.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ctns.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cystinosis: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_ctns.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Nephropathic cystinosis</div></li><li class="half_rhythm"><div>Intermediate cystinosis</div></li><li class="half_rhythm"><div>Non-nephropathic cystinosis</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#ctns.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="ctns.TF.c.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#ctns.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="ctns.Diagnosis"><h2 id="_ctns_Diagnosis_">Diagnosis</h2><p><i>Cystinosis Standards of Care</i> [<a class="bk_pop" href="#ctns.REF.nesterova.2012">Nesterova &#x00026; Gahl 2012</a>], developed and approved by international experts on cystinosis, is available <a href="https://www.cystinosis.org/wp-content/uploads/2019/01/CRN_StandardsOfCare_FINAL-1.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>.</p><div id="ctns.Suggestive_Findings"><h3>Suggestive Findings</h3><p><b>Nephropathic cystinosis should be suspected</b> in infants and young children with the following clinical, laboratory, and radiographic features.</p><p><b>Clinical</b></p><ul><li class="half_rhythm"><div>Failure to thrive and growth retardation from age six months</div></li><li class="half_rhythm"><div>Vomiting; feeding difficulties</div></li><li class="half_rhythm"><div>Severe polyuria, polydipsia, and dehydration</div></li><li class="half_rhythm"><div>Progressive rachitic skeletal changes; failure to walk at a normal age</div></li><li class="half_rhythm"><div>Tetany</div></li></ul><p><b>Laboratory</b></p><ul><li class="half_rhythm"><div>Hypochloremic metabolic acidosis</div></li><li class="half_rhythm"><div>Renal Fanconi syndrome: increased urinary excretion of electrolytes (sodium, potassium, bicarbonate), minerals (calcium, phosphate, magnesium), glucose, amino acids, tubular protein including &#x003b2;2-microglobulin</div></li><li class="half_rhythm"><div>Elevated serum alkaline phosphatase, hypocalcemia, hypophosphatemia, hypokalemia</div></li></ul><p><b>Radiographic</b></p><ul><li class="half_rhythm"><div>Radiographic features of rickets including: bowing of the long bones in the lower extremities; metaphyses may be widened and epiphyses frayed or cupped; generalized osteopenia</div></li><li class="half_rhythm"><div>Renal ultrasound examination showing medullary nephrocalcinosis and/or increased echogenicity</div></li></ul><p><b>Intermediate nephropathic cystinosis (juvenile/late onset)</b>
<b>should be suspected</b> in individuals exhibiting renal tubular Fanconi syndrome combined with progressive chronic glomerular insufficiency leading to end-stage renal disease (ESRD).</p><p><b>Ocular (non-nephropathic) cystinosis should be suspected</b> in adults with photophobia and/or cystine crystals in the cornea on slit lamp examination (see <a class="figpopup" href="/books/NBK1400/figure/ctns.F1/?report=objectonly" target="object" rid-figpopup="figctnsF1" rid-ob="figobctnsF1">Figure 1b</a>).</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figctnsF1" co-legend-rid="figlgndctnsF1"><a href="/books/NBK1400/figure/ctns.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figctnsF1" rid-ob="figobctnsF1"><img class="small-thumb" src="/books/NBK1400/bin/ctns-Image001.gif" src-large="/books/NBK1400/bin/ctns-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndctnsF1"><h4 id="ctns.F1"><a href="/books/NBK1400/figure/ctns.F1/?report=objectonly" target="object" rid-ob="figobctnsF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Findings on slit lamp examination of the cornea in cystinosis a. Band keratopathy in a 33-year-old treated with cysteamine eye drops, which dissolved the cystine crystals, but not the calcified band</p></div></div></div><div id="ctns.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of cystinosis <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by ONE of the following:</p><ul><li class="half_rhythm"><div>Identification of cystine crystals in the cornea on slit lamp examination visible after age 12 months, and always present after age of 16 months (see <a class="figpopup" href="/books/NBK1400/figure/ctns.F1/?report=objectonly" target="object" rid-figpopup="figctnsF1" rid-ob="figobctnsF1">Figure 1b</a>)</div></li><li class="half_rhythm"><div>Identification of elevated cystine concentration in polymorphonuclear leukocytes</div></li><li class="half_rhythm"><div>Demonstration of increased cystine content in cultured fibroblasts or in the placenta at the time of birth</div></li><li class="half_rhythm"><div>Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CTNS</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1400/table/ctns.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figctnsTmoleculargenetictestingusedin" rid-ob="figobctnsTmoleculargenetictestingusedin">Table 1</a>)</div></li></ul><p><b>Elevated cystine concentration in polymorphonuclear leukocytes</b> is best identified using mass spectrometry [<a class="bk_pop" href="#ctns.REF.gahl.2001">Gahl et al 2001</a>, <a class="bk_pop" href="#ctns.REF.gahl.2002.111">Gahl et al 2002</a>]:</p><ul><li class="half_rhythm"><div>Individuals with nephropathic cystinosis generally have values of 3.0-23.0 nmol half-cystine/mg protein.</div></li><li class="half_rhythm"><div>Individuals with non-nephropathic cystinosis have values of 1.0-3.0 nmol half-cystine/mg protein.</div></li><li class="half_rhythm"><div>Heterozygotes have &#x02264;1.0 nmol half-cystine/mg protein.</div></li><li class="half_rhythm"><div>Normal values are &#x02264;0.2 nmol half-cystine/mg protein.</div></li></ul><p>Note: (1) In preparing leukocytes for assay, care must be taken to avoid: (a) a significant number of lymphocytes, which store only fivefold normal amounts of cystine compared with 50-fold normal amounts in polymorphonuclear leukocytes; and (b) contamination with red blood cells, which contribute protein but not cystine to the calculated cystine value. Both interfering substances produce artifactually low leukocyte cystine levels. (2) Measurement by amino acid analysis (i.e., anion exchange chromatography) is less sensitive and can give spurious results if small amounts of leukocyte protein are available.</p><p><b>Other cystine measurements.</b> Cystinosis can also be diagnosed by the demonstration of increased cystine content in cultured fibroblasts or in the placenta at the time of birth [<a class="bk_pop" href="#ctns.REF.gahl.2001">Gahl et al 2001</a>].</p><p><b>Molecular genetic testing</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> For individuals of non-European ancestry, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>CTNS</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div><div class="half_rhythm">Targeted analysis for the <i>CTNS</i>
<a class="figpopup" href="/books/NBK1400/table/ctns.T.ctns_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figctnsTctnspathogenicvariantsdiscusse" rid-ob="figobctnsTctnspathogenicvariantsdiscusse">57-kb deletion</a> in individuals of northern European ancestry may be performed first. Targeted analysis of <i>CTNS</i> pathogenic variants, optimized for the French-Canadian population, may be performed first.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>CTNS</i> and other genes of interest (see <a href="#ctns.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>CTNS</i>) fails to confirm a diagnosis in an individual with features of cystinosis. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="ctns.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Cystinosis</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1400/table/ctns.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ctns.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ctns.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_ctns.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_ctns.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_ctns.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>CTNS</i></td><td headers="hd_h_ctns.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_ctns.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">56%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_ctns.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_ctns.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">44%&#x000a0;<sup>4</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ctns.TF.1.1"><p class="no_margin">See <a href="/books/NBK1400/#ctns.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="ctns.TF.1.2"><p class="no_margin">See <a href="#ctns.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="ctns.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="ctns.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#ctns.REF.shotelersuk.1998.1352">Shotelersuk et al [1998]</a>, <a class="bk_pop" href="#ctns.REF.attard.1999.2507">Attard et al [1999]</a></p></div></dd><dt>5. </dt><dd><div id="ctns.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div><div id="ctns.Clinical_Characteristics"><h2 id="_ctns_Clinical_Characteristics_">Clinical Characteristics</h2><div id="ctns.Clinical_Description"><h3>Clinical Description</h3><p>The three types of cystinosis &#x02012; nephropathic (classic renal and systemic disease), intermediate (a late-onset variant of nephropathic cystinosis), and non-nephropathic (ocular) &#x02012; are allelic disorders caused by pathogenic variants in <i>CTNS</i>.</p><div id="ctns.Nephropathic_and_Intermediate_Nephr"><h4>Nephropathic and Intermediate (Nephropathic) Cystinosis</h4><p><b>Nephropathic cystinosis.</b> The clinical characteristics of untreated nephropathic cystinosis include those associated with failure to thrive, poor growth, renal tubular Fanconi syndrome, renal glomerular failure, and non-renal involvement of a variety of tissues and organ systems. With effective cystine-depleting therapy, cystinosis was transformed from a progressive, fatal renal disease to a treatable chronic multisystemic disease, with life span increasing from about ten years to 50 years or more [<a class="bk_pop" href="#ctns.REF.nesterova.2008.863">Nesterova &#x00026; Gahl 2008</a>].</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Growth.</b> Infants with untreated nephropathic cystinosis are normal at birth. In untreated individuals, initially failure to thrive and later failure to grow are generally noticed between ages six and nine months. A high frequency of vomiting (usually in the morning), poor appetite, and feeding difficulties, combined with renal losses of nutrients, causes poor nutrition and severe failure to thrive. Typically, infants are at the third centile for height and weight at age one year [<a class="bk_pop" href="#ctns.REF.gahl.2001">Gahl et al 2001</a>, <a class="bk_pop" href="#ctns.REF.gahl.2002.111">Gahl et al 2002</a>]. Later, growth occurs at 60% of the normal rate. Bone age is usually delayed one to three years. Head circumference is normal for age.</div><div class="half_rhythm">With early and optimal symptomatic and cystine-depleting therapy, individuals grow at a normal rate. In the past, height often remained below the third centile and weight remained slightly above the third centile; however, recently, many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants and toddlers have height profiles following the 10th-25th centiles for age and falling in the range of mid-parental constitutional growth. Growth hormone administration improves height velocity in prepubertal children.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Renal tubular Fanconi syndrome.</b> Infants with untreated nephropathic cystinosis show signs of renal tubular Fanconi syndrome &#x02013; i.e., generalized proximal tubular dysfunction &#x02013; as early as age six months. The Fanconi syndrome involves failure of the renal tubules to reabsorb water, electrolytes, bicarbonate, phosphate, calcium, glucose, carnitine, amino acids, and tubular proteins. Individuals with untreated cystinosis have severe polyuria (2-6 L/day), polydipsia, dehydration, and hypochloremic metabolic acidosis, sometimes requiring hospitalization as a result of life-threatening hypovolemia, particularly during a gastrointestinal illness.</div><div class="half_rhythm">Hypophosphatemic/calcipenic rickets, characterized by high excretion of phosphate and calcium, elevated serum alkaline phosphatase, and bone deformities, make walking painful enough to delay ambulation. Nutritional deficiencies of vitamin D and calcium may accompany rickets, leading to seizures and tetany.</div><div class="half_rhythm">Severe hypokalemia can threaten cardiac conduction. Occasionally, hyponatremia and hypomagnesemia also occur.</div><div class="half_rhythm">Diligent treatment with replacement of renal losses is required for resolution of rickets, tetany, acidosis, and laboratory abnormalities. Cystine-depleting therapy begun just after birth when tubular damage is not complete can attenuate the renal tubular Fanconi syndrome [<a class="bk_pop" href="#ctns.REF.kleta.2004a.555">Kleta et al 2004a</a>]. However, renal tubular damage present at the usual time of diagnosis (i.e., age ~1 year) is irreversible [<a class="bk_pop" href="#ctns.REF.nesterova.2015.945">Nesterova et al 2015</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Renal glomerular failure.</b> In the natural history of untreated nephropathic cystinosis, glomerular function gradually deteriorates, resulting in renal failure at approximately age ten years [<a class="bk_pop" href="#ctns.REF.gahl.2001">Gahl et al 2001</a>, <a class="bk_pop" href="#ctns.REF.gahl.2002.111">Gahl et al 2002</a>].The serum creatinine concentration may not exceed 1.0 mg/dL until age five years, but once it rises, it increases exponentially. Many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have significant proteinuria, sometimes in nephrotic ranges, along with granular casts and microhematuria.</div><div class="half_rhythm">Early treatment with cystine-depleting therapy (i.e., oral cysteamine) slows or stops the progression of glomerular damage and can delay or eliminate the need for renal transplantation [<a class="bk_pop" href="#ctns.REF.kleta.2004a.555">Kleta et al 2004a</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Non-renal involvement.</b> Without optimal therapy, cystine accumulation occurs in virtually all organs and tissues, including bone marrow, liver, intestine, muscle, brain, spleen, eye, thyroid, pancreas, and testes. Without therapy, several complications of cystinosis occur prior to renal transplantation:</div><ul><li class="half_rhythm"><div>Children with cystinosis have mildly altered craniofacial morphology, reduced airway dimensions, delayed dental development, and delayed eruption of permanent teeth [<a class="bk_pop" href="#ctns.REF.bassim.2010.488">Bassim et al 2010</a>].</div></li><li class="half_rhythm"><div>Photophobia develops when the cornea becomes packed with crystals, generally at the end of the first decade of life.</div></li><li class="half_rhythm"><div>Affected individuals typically develop hypothyroidism at the end of the first decade of life.</div></li><li class="half_rhythm"><div>Sweating is impaired and <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals can suffer heat prostration [<a class="bk_pop" href="#ctns.REF.gahl.2001">Gahl et al 2001</a>, <a class="bk_pop" href="#ctns.REF.gahl.2002.111">Gahl et al 2002</a>].</div></li><li class="half_rhythm"><div>Benign intracranial hypertension presents with headaches and papilledema [<a class="bk_pop" href="#ctns.REF.dogulu.2004.673">Dogulu et al 2004</a>].</div></li><li class="half_rhythm"><div>Puberty is generally delayed one to two years. Untreated males exhibit primary hypogonadism [<a class="bk_pop" href="#ctns.REF.chik.1993.568">Chik et al 1993</a>].</div></li><li class="half_rhythm"><div>A male with cystinosis is reported to have fathered a child through in vitro fertilization, with the sperm obtained by testicular biopsy [<a class="bk_pop" href="#ctns.REF.veys.2018.1">Veys et al 2018</a>].</div></li><li class="half_rhythm"><div>Several females with untreated cystinosis have delivered healthy children [<a class="bk_pop" href="#ctns.REF.haase.2006.677">Haase et al 2006</a>].</div></li><li class="half_rhythm"><div>It is currently not known whether diligent cysteamine treatment can prevent primary hypogonadism in males.</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><b>Late-onset abnormalities.</b> Well after renal transplantation (i.e., at age ~20-40 years), another set of complications can occur from the long-standing accumulation of cystine crystals in non-renal organs in individuals not treated with cysteamine [<a class="bk_pop" href="#ctns.REF.servais.2008.27">Servais et al 2008</a>].</div><ul><li class="half_rhythm"><div>Increased cystine content in the muscles causes vacuolar myopathy in 60% of individuals [<a class="bk_pop" href="#ctns.REF.gahl.2007.242">Gahl et al 2007</a>]. Generalized myopathy leads to progressive muscle wasting and weakness (<a class="figpopup" href="/books/NBK1400/figure/ctns.F2/?report=objectonly" target="object" rid-figpopup="figctnsF2" rid-ob="figobctnsF2">Figure 2a</a>, <a class="figpopup" href="/books/NBK1400/figure/ctns.F2/?report=objectonly" target="object" rid-figpopup="figctnsF2" rid-ob="figobctnsF2">2c</a>, <a class="figpopup" href="/books/NBK1400/figure/ctns.F2/?report=objectonly" target="object" rid-figpopup="figctnsF2" rid-ob="figobctnsF2">2d</a>) [<a class="bk_pop" href="#ctns.REF.charnas.1994.181">Charnas et al 1994</a>]. Oral motor dysfunction causes swallowing and feeding difficulties [<a class="bk_pop" href="#ctns.REF.trauner.2001.365">Trauner et al 2001</a>, <a class="bk_pop" href="#ctns.REF.sonies.2005.137">Sonies et al 2005</a>]. Electromyography demonstrates a myopathic pattern.</div></li><li class="half_rhythm"><div>Extrinsic chest muscle impairment causes extraparenchymal restriction of ventilation leading to pulmonary insufficiency with decreased values of FVC and FEV1 on routine pulmonary function tests [<a class="bk_pop" href="#ctns.REF.anikster.2001.394">Anikster et al 2001</a>].</div></li><li class="half_rhythm"><div>Gastrointestinal findings can include reflux, dysmotility, esophagitis, gastric/duodenal ulcers, hepatomegaly with nodular regenerating hyperplasia of the liver with portal hypertension, exocrine pancreatic insufficiency [<a class="bk_pop" href="#ctns.REF.didomenico.2004.693">DiDomenico et al 2004</a>, <a class="bk_pop" href="#ctns.REF.o_brien.2006.387">O&#x02019;Brien et al 2006</a>], inflammatory bowel disease, bowel perforation, and peritonitis [<a class="bk_pop" href="#ctns.REF.gahl.2007.242">Gahl et al 2007</a>].</div></li><li class="half_rhythm"><div>Cardiovascular manifestations can include arteriopathy caused by the combination of vascular calcifications and obstructive atherosclerosis with hypercholesterolemia (<a class="figpopup" href="/books/NBK1400/figure/ctns.F2/?report=objectonly" target="object" rid-figpopup="figctnsF2" rid-ob="figobctnsF2">Figure 2e</a>) [<a class="bk_pop" href="#ctns.REF.ueda.2006.555">Ueda et al 2006</a>]; ESRD and renin-dependent hypertension; dilated cardiomyopathy; and aortic aneurysms. All of these factors contribute to cardiovascular morbidity and increase the risk for myocardial infarction and neurovascular incidents.</div></li><li class="half_rhythm"><div>Metabolic bone disease develops as a result of direct deposition of cystine crystals in bone, mineral imbalance, and renal osteodystrophy prior to renal transplantation [<a class="bk_pop" href="#ctns.REF.zimakas.2003.384">Zimakas et al 2003</a>].</div></li><li class="half_rhythm"><div>Hypercoagulopathy and hypocoagulopathy occur as a result of renal failure and platelet aggregation dysfunction [<a class="bk_pop" href="#ctns.REF.nesterova.2008.863">Nesterova &#x00026; Gahl 2008</a>].</div></li><li class="half_rhythm"><div>CNS calcifications (<a class="figpopup" href="/books/NBK1400/figure/ctns.F2/?report=objectonly" target="object" rid-figpopup="figctnsF2" rid-ob="figobctnsF2">Figure 2f</a>), benign intracranial hypertension with non-absorptive hydrocephalus, and parenchymal deterioration of the central nervous system with cerebral atrophy lead to various degrees of encephalopathy [<a class="bk_pop" href="#ctns.REF.gahl.2001">Gahl et al 2001</a>, <a class="bk_pop" href="#ctns.REF.gahl.2002.111">Gahl et al 2002</a>]. Occasionally, cerebrovascular incidents with paresis or pseudobulbar palsy occur [<a class="bk_pop" href="#ctns.REF.gahl.2007.242">Gahl et al 2007</a>].</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><b>Intellectual abilities</b> are low-normal; <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children have mainly average school performance. They have impaired visual and spatial cognition with preserved language and intellectual function [<a class="bk_pop" href="#ctns.REF.spilkin.2007.444">Spilkin et al 2007</a>]. Their distinctive behavioral and psychosocial difficulties stem from the chronic disease: ESRD, renal dialysis, prolonged hospitalizations, and treatment with multiple therapeutic agents, including steroids [<a class="bk_pop" href="#ctns.REF.ballantyne.2000.254">Ballantyne &#x00026; Trauner 2000</a>, <a class="bk_pop" href="#ctns.REF.delgado.2005.403">Delgado et al 2005</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Late ocular complications</b>. Crystal deposition in the anterior chamber, iris, ciliary body, choroid, fundus, and optic nerve manifests as [<a class="bk_pop" href="#ctns.REF.tsilou.2007.97">Tsilou et al 2007</a>]:</div><ul><li class="half_rhythm"><div>Anterior segment problems. Crystals in the anterior lens surface, band keratopathy (<a class="figpopup" href="/books/NBK1400/figure/ctns.F1/?report=objectonly" target="object" rid-figpopup="figctnsF1" rid-ob="figobctnsF1">Figure 1a</a>), peripheral corneal neovascularization, and posterior synechiae;</div></li><li class="half_rhythm"><div>Posterior segment problems. Pigmentary retinopathy with degeneration of the photoreceptors that contributes to the impaired visual function in the late stage of the disease [<a class="bk_pop" href="#ctns.REF.tsilou.2002.173">Tsilou et al 2002</a>].</div></li></ul></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figctnsF2" co-legend-rid="figlgndctnsF2"><a href="/books/NBK1400/figure/ctns.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figctnsF2" rid-ob="figobctnsF2"><img class="small-thumb" src="/books/NBK1400/bin/ctns-Image002.gif" src-large="/books/NBK1400/bin/ctns-Image002.jpg" alt="Figure 2. " /></a><div class="icnblk_cntnt" id="figlgndctnsF2"><h4 id="ctns.F2"><a href="/books/NBK1400/figure/ctns.F2/?report=objectonly" target="object" rid-ob="figobctnsF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">A man age 37 years with nephropathic cystinosis a. Thin habitus</p></div></div><p><b>Intermediate cystinosis.</b> All the early manifestations of untreated nephropathic cystinosis, including the renal tubular Fanconi syndrome, growth delay, photophobia, and glomerular failure, occur in individuals with untreated intermediate cystinosis, but at a later age, mostly during adolescence.</p><p><b>Histopathology.</b> Electron microscopy of the glomeruli reveals fusion of foot processes, thickening of Bowman&#x02019;s membrane, and localization of cystine crystals in interstitial cells. Cystinotic glomeruli show focal glomerulosclerosis [<a class="bk_pop" href="#ctns.REF.mahoney.2000.50">Mahoney &#x00026; Striker 2000</a>].</p><p><b>Pathophysiology.</b> The pathophysiology of renal tubular Fanconi syndrome is under investigation. Several mechanisms have been suggested:</p><ul><li class="half_rhythm"><div>Inhibition of the Na-phosphate cotransporter resulting from cystine accumulation in the proximal tubular cells with depletion of intracellular ATP [<a class="bk_pop" href="#ctns.REF.baum.1998.492">Baum 1998</a>, <a class="bk_pop" href="#ctns.REF.kleta.2002.2189">Kleta &#x00026; Gahl 2002</a>, <a class="bk_pop" href="#ctns.REF.park.2002.2878">Park et al 2002</a>]</div></li><li class="half_rhythm"><div>Degeneration of the proximal tubules, which is well documented in nephropathic cystinosis [<a class="bk_pop" href="#ctns.REF.mahoney.2000.50">Mahoney &#x00026; Striker 2000</a>]</div></li><li class="half_rhythm"><div>Inappropriately increased apoptosis, leading to progressive cell death in proximal tubules resulting in atubular glomeruli and renal failure [<a class="bk_pop" href="#ctns.REF.larsen.2010.417">Larsen et al 2010</a>]</div></li><li class="half_rhythm"><div>Increased sensitivity of ATP-induced Ca<sup>2+</sup>release in tubular cells [<a class="bk_pop" href="#ctns.REF.ivanova.2015.e0120998">Ivanova et al 2015</a>]</div></li><li class="half_rhythm"><div>Altered cell signaling resulting in impaired cell adhesion and enhanced cell motility [<a class="bk_pop" href="#ctns.REF.ivanova.2016.1037">Ivanova et al 2016</a>]</div></li></ul></div><div id="ctns.NonNephropathic_Cystinosis"><h4>Non-Nephropathic Cystinosis</h4><p>Individuals with untreated ocular cystinosis experience only photophobia.</p></div></div><div id="ctns.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Some <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> can be made:</p><ul><li class="half_rhythm"><div>Within the group of individuals with nephropathic cystinosis, truncating <i>CTNS</i> pathogenic variants, as well as the <a class="figpopup" href="/books/NBK1400/table/ctns.T.ctns_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figctnsTctnspathogenicvariantsdiscusse" rid-ob="figobctnsTctnspathogenicvariantsdiscusse">57-kb deletion</a>, result in severe, classic (early-onset or infantile type) disease [<a class="bk_pop" href="#ctns.REF.shotelersuk.1998.1352">Shotelersuk et al 1998</a>, <a class="bk_pop" href="#ctns.REF.attard.1999.2507">Attard et al 1999</a>].</div></li><li class="half_rhythm"><div>Individuals with apparent residual activity (i.e., lower levels of cystine accumulation in leukocytes) often have <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in <i>CTNS</i> [<a class="bk_pop" href="#ctns.REF.attard.1999.2507">Attard et al 1999</a>]. Individuals with intermediate cystinosis (i.e., nephropathic but late onset) or non-nephropathic cystinosis (i.e., corneal and bone marrow crystals but no renal involvement) have one severe <i>CTNS</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, typical for nephropathic cystinosis, and one mild pathogenic variant. The mild variants include <a class="figpopup" href="/books/NBK1400/table/ctns.T.ctns_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figctnsTctnspathogenicvariantsdiscusse" rid-ob="figobctnsTctnspathogenicvariantsdiscusse">p.Gly197Arg</a> and <a class="figpopup" href="/books/NBK1400/table/ctns.T.ctns_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figctnsTctnspathogenicvariantsdiscusse" rid-ob="figobctnsTctnspathogenicvariantsdiscusse">c.853-3C&#x0003e;G</a> [<a class="bk_pop" href="#ctns.REF.anikster.1999.454">Anikster et al 1999</a>]. The organ specificity in benign cystinosis may result from tissue-specific <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> factors.</div></li><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1400/table/ctns.T.ctns_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figctnsTctnspathogenicvariantsdiscusse" rid-ob="figobctnsTctnspathogenicvariantsdiscusse">p.Ser139Phe</a> may cause the juvenile <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#ctns.REF.mac_asvidal.2009.486">Mac&#x000ed;as-Vidal et al 2009</a>].</div></li><li class="half_rhythm"><div>Deletions of <i>CTNS</i> and its flanking genes may lead to <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> syndromes with more complex phenotypes than those of classic cystinosis [<a class="bk_pop" href="#ctns.REF.kalatzis.2003.207">Kalatzis &#x00026; Antignac 2003</a>]. For example, the 57-kb deletion on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 17p13 extends into <i>TRPV1</i> causing dysregulation of <i>TRPV1</i> transcription in peripheral blood mononuclear cells [<a class="bk_pop" href="#ctns.REF.freed.2011.563">Freed et al 2011</a>].</div></li><li class="half_rhythm"><div>Heterozygotes have 50% of transport capacity in their lysosomes [<a class="bk_pop" href="#ctns.REF.thoene.1995.380">Thoene 1995</a>, <a class="bk_pop" href="#ctns.REF.gahl.2002.111">Gahl et al 2002</a>].</div></li><li class="half_rhythm"><div>Loss of cystinosin may result in the unregulated activation of other transporters and pathways, including redox-based signaling or protein cysteinylation [<a class="bk_pop" href="#ctns.REF.bellomo.2010.865">Bellomo et al 2010</a>]. Other lysosomal functions may also be impaired in cystinosis [<a class="bk_pop" href="#ctns.REF.wilmer.2010.f905">Wilmer et al 2010</a>]. Studies of whole-genome expression profiles in peripheral blood samples from people with cystinosis identified modifier genes and pathways associated with nephropathic cystinosis; further investigation is needed to confirm the role of these genes in modulating the cystinosis <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#ctns.REF.sansanwal.2010.775">Sansanwal et al 2010</a>].</div></li></ul></div><div id="ctns.Nomenclature"><h3>Nomenclature</h3><p>Nephropathic cystinosis is also referred to as infantile nephropathic type cystinosis.</p><p>Intermediate cystinosis is also referred to as adolescent (or juvenile) nephropathic type cystinosis.</p><p>The terms "adult cystinosis" and "benign cystinosis" should be replaced by "ocular cystinosis," "non-nephropathic cystinosis," or "ocular non-nephropathic cystinosis."</p></div><div id="ctns.Prevalence"><h3>Prevalence</h3><p>Cystinosis occurs with a frequency of approximately one in 100,000 to 200,000 and has been found worldwide in all ethnic groups. The frequency of cystinosis in Brittany has been given as one in 26,000 [<a class="bk_pop" href="#ctns.REF.gahl.2001">Gahl et al 2001</a>, <a class="bk_pop" href="#ctns.REF.gahl.2002.111">Gahl et al 2002</a>].</p><p>Cystinosis accounts for 5% of childhood renal failure [<a class="bk_pop" href="#ctns.REF.middleton.2003.2492">Middleton et al 2003</a>].</p></div></div><div id="ctns.Genetically_Related_Allelic_Disorde"><h2 id="_ctns_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>CTNS</i>.</p></div><div id="ctns.Differential_Diagnosis"><h2 id="_ctns_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Renal tubular Fanconi syndrome.</b> Untreated nephropathic cystinosis is the most common identifiable cause of renal tubular Fanconi syndrome in childhood. Other causes include:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/wilson/">Wilson disease</a> is a disorder of copper metabolism that can present with hepatic, neurologic, or psychiatric disturbances or a combination of these; onset ranges from age three to older than 50. Diagnosis depends in part on the detection of low serum copper and ceruloplasmin concentrations, Kayser-Fleischer rings in the cornea, and/or increased urinary copper excretion. Pathogenic variants in <i>ATP7B</i> are causative. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/lowe/">Lowe syndrome</a> (oculocerebrorenal syndrome) is found in males and involves the eyes (cataracts, glaucoma, decreased visual acuity), central nervous system (hypotonia, intellectual disability), and kidneys (Fanconi syndrome). Slowly progressive glomerulosclerosis and renal failure are often noted after age ten years. It is diagnosed by demonstrating reduced (&#x0003c;10% of normal) activity of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in cultured skin fibroblasts. A <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>OCRL</i> is detectable in most males and <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females. (Mutation of <i>OCRL1</i> can also cause <a href="/books/n/gene/dent/">Dent disease</a>, which can present with findings typical for renal Fanconi syndrome.) Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/galactosemia/">Classic galactosemia</a> is a disorder of galactose metabolism that can result in feeding problems, failure to thrive, hepatocellular damage, bleeding, and sepsis in untreated infants. It is most often caused by deficient activity of the enzyme galactose-1-phosphate uridyltransferase (GALT). The diagnosis of classic galactosemia is established by detection of elevated erythrocyte galactose-1-phosphate concentration, reduced erythrocyte GALT enzyme activity, and/or <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>GALT</i>. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/gsd1/">Glycogen storage disease type I</a> presents mainly with hepatomegaly and hypoglycemia.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/tyrosinemia/">Tyrosinemia type I</a> presents with severe liver disease in infancy and shows abnormal tyrosine metabolites on organic acid analyses.</div></li><li class="half_rhythm"><div>Glucosuria associated with renal tubular Fanconi syndrome can result in misdiagnosis as diabetes mellitus.</div></li><li class="half_rhythm"><div>Polyuria often leads to a misdiagnosis of diabetes insipidus (see <a href="/books/n/gene/ndi/">Nephrogenic Diabetes Insipidus</a>).</div></li><li class="half_rhythm"><div>Electrolyte abnormalities can suggest Bartter syndrome.</div></li><li class="half_rhythm"><div>The rickets of cystinosis can falsely suggest vitamin D-deficient rickets.</div></li></ul><p><b>Ocular (non-nephropathic) cystinosis.</b> Multiple myeloma can cause photophobia and corneal crystals similar to those in ocular cystinosis [<a class="bk_pop" href="#ctns.REF.kleta.2004b.410">Kleta et al 2004b</a>].</p></div><div id="ctns.Management"><h2 id="_ctns_Management_">Management</h2><p>Clinical practice guidelines for the treatment of individuals with cystinosis, developed and approved by international experts on cystinosis, have been published. See <a href="https://www.cystinosis.org/wp-content/uploads/2019/01/CRN_StandardsOfCare_FINAL-1.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Cystinosis Standards of Care</a> [<a class="bk_pop" href="#ctns.REF.nesterova.2012">Nesterova &#x00026; Gahl 2012</a>].</p><div id="ctns.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with cystinosis, the following evaluations are recommended.</p><p>In individuals who are initially diagnosed at any age:</p><ul><li class="half_rhythm"><div>Height and weight, plotted on age-appropriate growth charts</div></li><li class="half_rhythm"><div>Renal tubular and glomerular function, especially serum concentrations of creatinine, phosphate, bicarbonate, and potassium; and urine concentrations of creatinine, phosphate, bicarbonate, potassium, glucose, and protein. Quantitative measurement of urine amino acid loss helps to identify the severity of renal Fanconi syndrome [<a class="bk_pop" href="#ctns.REF.charnas.1991.1318">Charnas et al 1991</a>].</div></li><li class="half_rhythm"><div>Glomerular filtration rate (GFR) or creatinine clearance test</div></li><li class="half_rhythm"><div>Thyroid function studies</div></li><li class="half_rhythm"><div>Lipid panel</div></li><li class="half_rhythm"><div>Renal ultrasound examination for evaluation of nephrocalcinosis</div></li><li class="half_rhythm"><div>Ophthalmologic evaluation, including slit lamp examination of the cornea to assess corneal involvement, ERG to assess retinal involvement, and fundoscopic examination for possible intracranial hypertension</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul><p>In individuals who are initially diagnosed at an older age:</p><ul><li class="half_rhythm"><div>In pre- and postpubertal males, measurement of serum concentration of testosterone, FSH, and LH</div></li><li class="half_rhythm"><div>Glucose tolerance test to assess for diabetes mellitus if symptoms are present</div></li><li class="half_rhythm"><div>Baseline ophthalmology evaluation, including a fundoscopic examination</div></li><li class="half_rhythm"><div>Evaluation of the extent of metabolic bone disease causing skeletal deformities by performing skeletal radiographs and DEXA scan</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="ctns.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>It is recommended that a multidisciplinary team that includes nephrologists, metabolic disease specialists, ophthalmologists, neurologists, gastroenterologists, nutritionists, and psychologists manage individuals with cystinosis.</p><p><b>Renal Fanconi syndrome</b></p><ul><li class="half_rhythm"><div>Replacement of tubular losses of electrolytes, bicarbonate, minerals, and other small molecular weight nutrients</div></li><li class="half_rhythm"><div>For children, free access to water and bathroom privileges and supplementation with citrate to alkalinize the blood</div></li><li class="half_rhythm"><div>Phosphate replacement to prevent and treat rickets; vitamin D supplementation to assist the gastrointestinal absorption of phosphate and calcium</div></li><li class="half_rhythm"><div>Early treatment of skeletal deformities with the help of orthopedic specialists</div></li><li class="half_rhythm"><div>Careful attention to fluid and nutrient replacement is required during episodes of dehydration. (Obligatory urinary losses amount to 2-6 L electrolyte-rich water per day.)</div></li></ul><p><b>Renal glomerular disease</b></p><ul><li class="half_rhythm"><div>Reduction of cellular cystine concentration through treatment with the cystine-depleting agent cysteamine (see <a href="#ctns.Prevention_of_Primary_Manifestation">Prevention of Primary Manifestations</a>).</div></li><li class="half_rhythm"><div>Renal transplantation. Renal replacement is usually indicated when the creatinine clearance falls below 20 mL/min/1.73 m<sup>2</sup> and azotemia and hypertension rapidly progress. The time frame for appropriate renal replacement is the point at which the reciprocal serum creatinine value plotted against age reaches approximately 0.1. Symptoms often determine the exact time of transplantation.</div></li></ul><p><b>Ophthalmologic problems</b> are treated symptomatically and with cystine-depleting agents:</p><ul><li class="half_rhythm"><div>The photophobia, resulting from corneal crystal accumulation, can be ameliorated by sun avoidance, dark glasses, and lubrication with over-the-counter eye drops (see <a href="#ctns.Prevention_of_Primary_Manifestation">Prevention of Primary Manifestations</a>).</div></li><li class="half_rhythm"><div>Corneal transplantation is very rarely required for intractable pain resulting from recurrent corneal ulcerations.</div></li><li class="half_rhythm"><div>Retinal involvement is irreversible.</div></li></ul><p><b>Growth</b> for children with cystinosis requires good nutrition, adequate phosphate supplementation, and robust intracellular cystine depletion (see <a href="#ctns.Prevention_of_Primary_Manifestation">Prevention of Primary Manifestations</a>):</p><ul><li class="half_rhythm"><div>Nutrition must be adequate for growth.</div></li><li class="half_rhythm"><div>Growth hormone therapy has proven beneficial for children with cystinosis in providing catch-up growth and bringing them into the normal centiles for height [<a class="bk_pop" href="#ctns.REF.gahl.2001">Gahl et al 2001</a>, <a class="bk_pop" href="#ctns.REF.w_hl.2001.880">W&#x000fc;hl et al 2001</a>, <a class="bk_pop" href="#ctns.REF.gahl.2002.111">Gahl et al 2002</a>].</div></li><li class="half_rhythm"><div>Early and diligent treatment with supplements and oral cysteamine can obviate the need for growth hormone [<a class="bk_pop" href="#ctns.REF.kleta.2004a.555">Kleta et al 2004a</a>].</div></li></ul><p><b>Other</b></p><ul><li class="half_rhythm"><div>Oral L-thyroxine replacement for hypothyroidism</div></li><li class="half_rhythm"><div>Insulin for diabetes mellitus</div></li><li class="half_rhythm"><div>Testosterone to induce secondary sexual characteristics in males with primary hypogonadism</div></li><li class="half_rhythm"><div>Specific exercises for the muscle deterioration and swallowing difficulties of older individuals with cystinosis. Hand tendon transfer has been partially successful in improving strength.</div></li><li class="half_rhythm"><div>Speech therapy and physical therapy</div></li><li class="half_rhythm"><div>Standard treatment for benign intracranial hypertension. Other central nervous system complications are irreversible.</div></li><li class="half_rhythm"><div>Feeding via gastrostomy for those with dysphagia, poor nutrition, and risk of aspiration (<a class="figpopup" href="/books/NBK1400/figure/ctns.F2/?report=objectonly" target="object" rid-figpopup="figctnsF2" rid-ob="figobctnsF2">Figure 2b</a>)</div></li></ul></div><div id="ctns.Prevention_of_Primary_Manifestation"><h3>Prevention of Primary Manifestations</h3><p><b>Cystine depletion therapy</b> with cysteamine bitartrate (Cystagon<sup>&#x000ae;</sup>) has revolutionized the management and prognosis of people with nephropathic cystinosis. Cysteamine is now the worldwide treatment of choice for cystinosis. This free thiol can deplete cystinotic cells of more than 90% of their cystine content [<a class="bk_pop" href="#ctns.REF.kleta.2004.2255">Kleta &#x00026; Gahl 2004</a>]. <a class="bk_pop" href="#ctns.REF.wilmer.2011.643">Wilmer et al [2011]</a> found that cysteamine also increased intracellular glutathione levels and restored the glutathione redox status of cystinotic cells.</p><p>Cysteamine therapy should be considered for all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, regardless of age and transplantation status [<a class="bk_pop" href="#ctns.REF.gahl.2007.242">Gahl et al 2007</a>]. With early, diligent treatment many individuals with cystinosis have survived into their twenties without the need for renal transplantation [<a class="bk_pop" href="#ctns.REF.gahl.2002.111">Gahl et al 2002</a>].</p><ul><li class="half_rhythm"><div>Regular and diligent cysteamine therapy prevents or delays end-stage renal disease (ESRD) [<a class="bk_pop" href="#ctns.REF.markello.1993.1157">Markello et al 1993</a>] and hypothyroidism, enhances growth, and depletes muscle parenchyma of cystine [<a class="bk_pop" href="#ctns.REF.gahl.2002.111">Gahl et al 2002</a>].</div></li><li class="half_rhythm"><div>It is critical to initiate cysteamine therapy immediately after diagnosis to allow for kidney growth and acquisition, rather than loss, of renal function [<a class="bk_pop" href="#ctns.REF.kleta.2004a.555">Kleta et al 2004a</a>].</div></li><li class="half_rhythm"><div>Cystagon<sup>&#x000ae;</sup> is taken orally every six hours at 60 to 90 mg of free base per kg per day (1.3 to 1.95 g/m<sup>2</sup>/day). The recommended adult dose is 500 mg free base every six hours; however, for both children and adults, the dose is titrated to reduce, if possible, leukocyte cystine concentration (measured 5-6 hours after a dose) to below 1.0 nmol half-cystine/mg protein [<a class="bk_pop" href="#ctns.REF.belldina.2003.520">Belldina et al 2003</a>, <a class="bk_pop" href="#ctns.REF.kleta.2004.2255">Kleta &#x00026; Gahl 2004</a>, <a class="bk_pop" href="#ctns.REF.kleta.2006.718">Kleta 2006</a>].</div></li><li class="half_rhythm"><div>Procysbi<sup>&#x000ae;</sup> (cysteamine bitartrate) is a delayed-release capsule intended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals age six years and older. Procysbi<sup>&#x000ae;</sup> is taken every 12 hours. Blood testing showed Procysbi<sup>&#x000ae;</sup> was noninferior to Cystagon<sup>&#x000ae;</sup> in controlling cystine levels [<a class="bk_pop" href="#ctns.REF.langman.2012.1112">Langman et al 2012</a>].</div></li><li class="half_rhythm"><div>Side effects of cysteamine treatment include nausea and vomiting, in part because of its unpleasant odor and taste [<a class="bk_pop" href="#ctns.REF.schneider.2004.436">Schneider 2004</a>]. Cysteamine increases gastrin synthesis and gastric acid production. Omeprazole may be of benefit for oral cysteamine treatment [<a class="bk_pop" href="#ctns.REF.dohil.2003.224">Dohil et al 2003</a>].</div></li><li class="half_rhythm"><div>With long-term cystine-depleting therapy most late complications of cystinosis can be avoided.</div></li><li class="half_rhythm"><div>Despite diligent oral cysteamine therapy, cysteamine hydrochloride eye drops or CYSTARAN<sup>&#x02122;</sup> (cysteamine ophthalmic solution) 0.44% are required to achieve sufficient tissue concentration to dissolve corneal crystals [<a class="bk_pop" href="#ctns.REF.gahl.2000.100">Gahl et al 2000</a>]. Cysteamine eye drops are given ten to 12 times per day as a 0.55% solution with benzalkonium chloride 0.01% as a preservative [<a class="bk_pop" href="#ctns.REF.tsilou.2007.97">Tsilou et al 2007</a>]. With good compliance photophobia is relieved within weeks (<a class="figpopup" href="/books/NBK1400/figure/ctns.F1/?report=objectonly" target="object" rid-figpopup="figctnsF1" rid-ob="figobctnsF1">Figure 1b</a>, <a class="figpopup" href="/books/NBK1400/figure/ctns.F1/?report=objectonly" target="object" rid-figpopup="figctnsF1" rid-ob="figobctnsF1">1c</a>) [<a class="bk_pop" href="#ctns.REF.kaiserkupfer.1987.775">Kaiser-Kupfer et al 1987</a>, <a class="bk_pop" href="#ctns.REF.gahl.2000.100">Gahl et al 2000</a>]. Systemic cysteamine treatment ameliorates or postpones retinal deterioration [<a class="bk_pop" href="#ctns.REF.tsilou.2006.1002">Tsilou et al 2006</a>].</div></li></ul></div><div id="ctns.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>Affected individuals who have undergone a renal transplantation should be monitored for the signs of immunodeficiency and infection.</p><p>Carnitine supplementation may improve muscle strength in pre-transplant individuals.</p><p>Treatment with proton pump inhibitors, such as omeprazole, relieves cysteamine-induced gastric acid hypersecretion and improves gastrointestinal symptoms [<a class="bk_pop" href="#ctns.REF.osefo.2009.433">Osefo et al 2009</a>].</p></div><div id="ctns.Surveillance"><h3>Surveillance</h3><p>Clinical and laboratory examinations should be performed in individuals with nephropathic cystinosis according to disease severity and may include renal, endocrine, ophthalmologic, neurologic, and cardiac examinations [<a class="bk_pop" href="#ctns.REF.kleta.2005.452">Kleta et al 2005</a>]:</p><ul><li class="half_rhythm"><div>Evaluation by a nephrologist every three to six months depending on the severity of renal impairment</div></li><li class="half_rhythm"><div>Renal function tests, electrolytes, and thyroid function tests at least every three to six months in those who are stable</div></li><li class="half_rhythm"><div>Serum concentration of calcium, phosphate, alkaline phosphatase, and intact parathyroid hormone; plain bone radiographs as well as DEXA scans to detect osteopenia and bone fragility predisposing to fractures, starting as soon as diagnosis is made and continued throughout the course of the disease</div></li><li class="half_rhythm"><div>Ophthalmologic evaluation with fundoscopic examination to screen for increased intracranial pressure every one to two years for those being treated appropriately</div></li><li class="half_rhythm"><div>Fasting blood glucose concentration throughout the course of the disease and testosterone concentration (in males) every two to three years, starting before puberty</div></li><li class="half_rhythm"><div>In advanced disease (i.e., poorly treated adults) and in late stages of disease, perform every two to three years:</div><ul><li class="half_rhythm"><div>Chest CT for detection of coronary and other vascular calcification</div></li><li class="half_rhythm"><div>ECG</div></li><li class="half_rhythm"><div>Brain CT or MRI for evaluation of cerebral atrophy or calcifications</div></li><li class="half_rhythm"><div>Evaluation for the presence of progressive muscle weakness and swallowing difficulties using electromyography (EMG), oral sensorimotor examination, and modified barium swallowing studies with videofluoroscopy</div></li><li class="half_rhythm"><div>Pulmonary function tests</div></li><li class="half_rhythm"><div>Neurologic and neurocognitive evaluations including visual-motor integration, visual memory, planning, sustained attention, and motor speed beginning at age seven to eight years [<a class="bk_pop" href="#ctns.REF.besouw.2010a.787">Besouw et al 2010a</a>]</div></li></ul></li></ul></div><div id="ctns.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoid the following:</p><ul><li class="half_rhythm"><div>Dehydration, which compromises remaining renal function</div></li><li class="half_rhythm"><div>Sun exposure, which can exacerbate photophobia</div></li></ul></div><div id="ctns.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate relatives at risk (e.g., newborn sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>) in order to identify as early as possible those who would benefit from early treatment to prevent life-threatening complications of cystinosis.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the pathogenic variants in the family are known;</div></li><li class="half_rhythm"><div>Biochemical testing if the pathogenic variants in the family are not known.</div></li></ul><p>See <a href="#ctns.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="ctns.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Pregnancies in women with cystinosis are at increased risk for premature delivery and must be monitored closely [<a class="bk_pop" href="#ctns.REF.ramappa.2010.220">Ramappa &#x00026; Pyatt 2010</a>]. For women who are post-transplantation, the abdominal renal allograft creates mechanical issues. For women who have not undergone transplantation, fluid and electrolyte status require careful management.</p></div><div id="ctns.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Bone marrow-derived stem cell transplantation in mice improved chronic kidney disease [<a class="bk_pop" href="#ctns.REF.yeagy.2011.1198">Yeagy et al 2011</a>].</p><p>Search <a href="http://clinicaltrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div><div id="ctns.Other"><h3>Other</h3><p>Development of a <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> test for cystinosis will potentially allow broader therapeutic success [<a class="bk_pop" href="#ctns.REF.nesterova.2008.863">Nesterova &#x00026; Gahl 2008</a>]. Two methods have been proposed: tandem mass spectrometry for the determination of derivative seven-carbon (C7) sugars in dried blood spots (DBS), which detects homozygosity for the <i>CTNS</i> 57-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the most common <i>CTNS</i> pathogenic variants [<a class="bk_pop" href="#ctns.REF.wamelink.2011.339">Wamelink et al 2011</a>].</p><p>Therapies proven to be ineffective include dietary restriction of sulfur-containing amino acids, supplementation with ascorbic acid, and the use of dithiothreitol.</p></div></div><div id="ctns.Genetic_Counseling"><h2 id="_ctns_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="ctns.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>All forms of cystinosis are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="ctns.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>CTNS</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The offspring of an individual with cystinosis are obligate heterozygotes (carriers) for a <i>CTNS</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Rarely, families with two-generation involvement (sometimes called "pseudodominance") have been identified; two-generation involvement results from an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual having children with a partner who is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) for a <i>CTNS</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>CTNS</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="ctns.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p><b>Biochemical testing.</b> Carrier testing can be performed biochemically; it requires freshly prepared leukocytes and appropriate controls.</p><p><b>Molecular genetic testing.</b> Carrier testing for at-risk family members is possible if the pathogenic variants in the family are known.</p></div><div id="ctns.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#ctns.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li><li class="half_rhythm"><div>Women with cystinosis have had successful pregnancies resulting in healthy newborns; however, the potential teratogenic effects of cysteamine on fetuses have not been studied in humans.</div></li><li class="half_rhythm"><div>Very limited data on fertility in males with cystinosis exist; several individuals have been reported with aspermia. However, one individual had sufficient spermatogenesis in a testicular biopsy to father a child through in vitro fertilization [<a class="bk_pop" href="#ctns.REF.veys.2018.1">Veys et al 2018</a>]. Cryopreservation of sperm could be considered in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males [<a class="bk_pop" href="#ctns.REF.besouw.2010b.1880">Besouw et al 2010b</a>].</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="ctns.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Biochemical testing.</b> For pregnancies at risk for nephropathic cystinosis, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> is possible biochemically, based on elevated cystine concentrations in either chorionic villi or amniocytes obtained by amniocentesis [<a class="bk_pop" href="#ctns.REF.gahl.2001">Gahl et al 2001</a>].</p><p><b>Molecular genetic testing.</b> Once the <i>CTNS</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for cystinosis are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="ctns.Resources"><h2 id="_ctns_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Cystinosis Foundation</b></div><div><i>Links to international cystinosis consumer groups can be found on The Cystinosis Foundation homepage.</i></div><div><b>Phone:</b> 888-631-1588 (toll-free); 925-631-1588</div><div><a href="http://www.cystinosis.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cystinosis.com</a></div></li><li class="half_rhythm"><div><b>Cystinosis Ireland</b></div><div>Ireland</div><div><b>Email:</b> mail@cystinosis.ie</div><div><a href="http://www.cystinosis.ie/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cystinosis.ie</a></div></li><li class="half_rhythm"><div><b>Cystinosis Research Foundation Natalie's Wish</b></div><div>18802 Bardeen Avenue</div><div>Irvine CA 92612</div><div><a href="https://www.cystinosisresearch.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cystinosisresearch.org</a></div></li><li class="half_rhythm"><div><b>Cystinosis Research Network (CRN)</b></div><div>302 Whytegate Court</div><div>Lake Forest IL 60045</div><div><b>Phone:</b> 866-276-3669 (toll-free); 847-735-0471</div><div><b>Fax:</b> 847-235-2773</div><div><b>Email:</b> info@cystinosis.org</div><div><a href="http://www.cystinosis.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cystinosis.org</a></div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li></ul></div><div id="ctns.Molecular_Genetics"><h2 id="_ctns_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="ctns.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Cystinosis: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1400/table/ctns.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ctns.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_ctns.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_ctns.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_ctns.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_ctns.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_ctns.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_ctns.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_ctns.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1497" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CTNS</i></a></td><td headers="hd_b_ctns.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1497" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17p13<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_ctns.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O60931" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Cystinosin</a></td><td headers="hd_b_ctns.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/CTNS" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CTNS database</a></td><td headers="hd_b_ctns.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CTNS" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CTNS</a></td><td headers="hd_b_ctns.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CTNS[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CTNS</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="ctns.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="ctns.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Cystinosis (<a href="/omim/219750,219800,219900,606272" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1400/table/ctns.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ctns.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/219750" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">219750</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CYSTINOSIS, ADULT NONNEPHROPATHIC</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/219800" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">219800</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CYSTINOSIS, NEPHROPATHIC; CTNS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/219900" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">219900</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606272" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606272</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CYSTINOSIN; CTNS</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>CTNS</i> is 26 kb in length and has 12 exons with a <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> of 1,104 bp [<a class="bk_pop" href="#ctns.REF.town.1998.319">Town et al 1998</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1400/#ctns.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> At least 128 different pathogenic variants including promoter variants in <i>CTNS</i> have been reported in HGMD; they are found in different combinations in individuals with cystinosis [<a class="bk_pop" href="#ctns.REF.shotelersuk.1998.1352">Shotelersuk et al 1998</a>, <a class="bk_pop" href="#ctns.REF.town.1998.319">Town et al 1998</a>, <a class="bk_pop" href="#ctns.REF.attard.1999.2507">Attard et al 1999</a>, <a class="bk_pop" href="#ctns.REF.mcgowanjordan.1999.671">McGowan-Jordan et al 1999</a>, <a class="bk_pop" href="#ctns.REF.thoene.1999.283">Thoene et al 1999</a>, <a class="bk_pop" href="#ctns.REF.anikster.2000.17">Anikster et al 2000</a>, <a class="bk_pop" href="#ctns.REF.kleta.2001.332">Kleta et al 2001</a>, <a class="bk_pop" href="#ctns.REF.phornphutkul.2001.712">Phornphutkul et al 2001</a>, <a class="bk_pop" href="#ctns.REF.kalatzis.2002.439">Kalatzis et al 2002</a>, <a class="bk_pop" href="#ctns.REF.kiehntopf.2002.237">Kiehntopf et al 2002</a>, <a class="bk_pop" href="#ctns.REF.mason.2003.503">Mason et al 2003</a>]. Pathogenic variant types include <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants, deletions, and insertions leading to downstream stop codons or abolition of splice sites [<a class="bk_pop" href="#ctns.REF.kiehntopf.2002.237">Kiehntopf et al 2002</a>]. The missense variants are usually present within transmembrane regions [<a class="bk_pop" href="#ctns.REF.anikster.1999.454">Anikster et al 1999</a>]. There are no mutational hot spots.</p><p>By far the most common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) is the 57-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> involving exons 1-9 and part of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 10; this variant apparently represents a <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a> [<a class="bk_pop" href="#ctns.REF.shotelersuk.1998.1352">Shotelersuk et al 1998</a>]. Another relatively common pathogenic variant is p.Trp138Ter. A higher incidence of infantile cystinosis (1:26,000) was reported in the French province of Brittany. The <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variant c.898_900+24del27 segregates in certain unrelated families [<a class="bk_pop" href="#ctns.REF.kalatzis.2002.439">Kalatzis et al 2002</a>]. (For more information, see <a href="/books/NBK1400/#ctns.molgen.TA">Table A</a>.)</p><div id="ctns.T.ctns_pathogenic_variants_discusse" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>CTNS</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1400/table/ctns.T.ctns_pathogenic_variants_discusse/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ctns.T.ctns_pathogenic_variants_discusse_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">g.36,254_93,510del<br />(57-kb del)&#x000a0;<sup>1</sup></td><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/7239175" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AF168787</a></td></tr><tr><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.18_21del4</td><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr7PhefsTer7</td><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_3" rowspan="13" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?val=NM_004937.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004937<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/entrez/viewer.fcgi?val=NP_004928.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_004928<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.198_218del<br />(198del21bp or 537del21)&#x000a0;<sup>2</sup></td><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile67_Pro73del</td></tr><tr><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.382C&#x0003e;T</td><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln128Ter</td></tr><tr><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.397A&#x0003e;T</td><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile133Pro</td></tr><tr><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.414G&#x0003e;A</td><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp138Ter</td></tr><tr><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.416C&#x0003e;T</td><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser139Phe</td></tr><tr><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.473T&#x0003e;C</td><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu158Pro</td></tr><tr><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.544T&#x0003e;C</td><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp182Arg</td></tr><tr><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.589G&#x0003e;A</td><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly197Arg</td></tr><tr><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.611_613del3</td><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp205del</td></tr><tr><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.853-3C&#x0003e;G</td><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.898_900+24del27</td><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.922G&#x0003e;A</td><td headers="hd_h_ctns.T.ctns_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly308Arg</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="ctns.TF.2.1"><p class="no_margin"><a class="bk_pop" href="#ctns.REF.touchman.2000.165">Touchman et al [2000]</a></p></div></dd><dt>2. </dt><dd><div id="ctns.TF.2.2"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>3. </dt><dd><div id="ctns.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#ctns.REF.anikster.2000.17">Anikster et al [2000]</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Cystinosin, the protein product of <i>CTNS</i>, is a 367-amino acid peptide with seven transmembrane and two lysosomal targeting motifs, a 128-amino acid N-terminal region bearing seven potential N-glycosylation sites, and a ten-amino acid cytosolic C-terminal tail [<a class="bk_pop" href="#ctns.REF.town.1998.319">Town et al 1998</a>, <a class="bk_pop" href="#ctns.REF.kalatzis.2002.1883">Kalatzis &#x00026; Antignac 2002</a>, <a class="bk_pop" href="#ctns.REF.kalatzis.2003.207">Kalatzis &#x00026; Antignac 2003</a>]. Cystinosin is expressed in the cells of virtually all tissues. Cystinosin transports the disulfide amino acid cystine out of the lysosome and into the cytoplasm [<a class="bk_pop" href="#ctns.REF.gahl.2002.111">Gahl et al 2002</a>, <a class="bk_pop" href="#ctns.REF.kleta.2002.2189">Kleta &#x00026; Gahl 2002</a>]. Cystinosin is highly conserved between man and mouse [<a class="bk_pop" href="#ctns.REF.cherqui.2002.7622">Cherqui et al 2002</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <a class="figpopup" href="/books/NBK1400/table/ctns.T.ctns_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figctnsTctnspathogenicvariantsdiscusse" rid-ob="figobctnsTctnspathogenicvariantsdiscusse">57-kb deletion</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> produces no <i>CTNS</i> <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a>, while most other alleles produce some residual mRNA [<a class="bk_pop" href="#ctns.REF.shotelersuk.1998.1352">Shotelersuk et al 1998</a>]. The mutated alleles of <i>CTNS</i> are predicted to produce truncated cystinosin in the case of severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and to produce cystinosin that retains some residual function in the case of mildly affected individuals.</p></div><div id="ctns.References"><h2 id="_ctns_References_">References</h2><div id="ctns.Published_GuidelinesConsensus_State"><h3>Published Guidelines/Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.emma.2014">Emma F, Nesterova G, Langman C, Labb&#x000e9; A, Cherqui S, Goodyer P, Janssen MC, Greco M, Topaloglu R, Elenberg E, Dohil R, Trauner D, Antignac C, Cochat P, Kaskel F, Servais A, W&#x000fc;hl E, Niaudet P, Van't Hoff W, Gahl W, Levtchenko E. Nephropathic cystinosis: an international consensus document. Available <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158338/" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2014. Accessed 6-19-19. [<a href="/pmc/articles/PMC4158338/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4158338</span></a>] [<a href="/pubmed/25165189" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25165189</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.nesterova.2012">Nesterova G, Gahl WA. Infantile nephropathic cystinosis standards of care &#x02013; a reference for people with infantile nephropathic cystinosis, their families, and medical team. Cystinosis Research Network. Available <a href="https://www.cystinosis.org/wp-content/uploads/2019/01/CRN_StandardsOfCare_FINAL-1.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2012. Accessed 6-19-19.</div></li></ul></div><div id="ctns.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.anikster.2001.394">Anikster Y, Lacbawan F, Brantly M, Gochuico BL, Avila NA, Travis W, Gahl WA. Pulmonary dysfunction in adults with nephropathic cystinosis. <span><span class="ref-journal">Chest. </span>2001;<span class="ref-vol">119</span>:394–401.</span> [<a href="/pubmed/11171714" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11171714</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.anikster.2000.17">Anikster Y, Lucero C, Guo J, Huizing M, Shotelersuk V, Bernardini I, McDowell G, Iwata F, Kaiser-Kupfer MI, Jaffe R, Thoene J, Schneider JA, Gahl WA. Ocular nonnephropathic cystinosis: clinical, biochemical, and molecular correlations. <span><span class="ref-journal">Pediatr Res. </span>2000;<span class="ref-vol">47</span>:17–23.</span> [<a href="/pubmed/10625078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10625078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.anikster.1999.454">Anikster Y, Shotelersuk V, Gahl WA. CTNS mutations in patients with cystinosis. <span><span class="ref-journal">Hum Mutat. </span>1999;<span class="ref-vol">14</span>:454–8.</span> [<a href="/pubmed/10571941" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10571941</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.attard.1999.2507">Attard M, Jean G, Forestier L, Cherqui S, van't Hoff W, Broyer M, Antignac C, Town M. Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin. <span><span class="ref-journal">Hum Mol Genet. </span>1999;<span class="ref-vol">8</span>:2507–14.</span> [<a href="/pubmed/10556299" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10556299</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.ballantyne.2000.254">Ballantyne AO, Trauner DA. Neurobehavioral consequences of a genetic metabolic disorder: visual processing deficits in infantile nephropathic cystinosis. <span><span class="ref-journal">Neuropsychiatry Neuropsychol Behav Neurol. </span>2000;<span class="ref-vol">13</span>:254–63.</span> [<a href="/pubmed/11186161" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11186161</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.bassim.2010.488">Bassim CW, Gautam P, Domingo DL, Balog JZ, Guadagnini JP, Gahl WA, Hart TC. Craniofacial and dental findings in cystinosis. <span><span class="ref-journal">Oral Dis. </span>2010;<span class="ref-vol">16</span>:488–95.</span> [<a href="/pmc/articles/PMC2888839/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2888839</span></a>] [<a href="/pubmed/20233313" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20233313</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.baum.1998.492">Baum M. The Fanconi syndrome of cystinosis: insights into the pathophysiology. <span><span class="ref-journal">Pediatr Nephrol. </span>1998;<span class="ref-vol">12</span>:492–7.</span> [<a href="/pubmed/9745876" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9745876</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.belldina.2003.520">Belldina EB, Huang MY, Schneider JA, Brundage RC, Tracy TS. Steady-state pharmacokinetics and pharmacodynamics of cysteamine bitartrate in paediatric nephropathic cystinosis patients. <span><span class="ref-journal">Br J Clin Pharmacol. </span>2003;<span class="ref-vol">56</span>:520–5.</span> [<a href="/pmc/articles/PMC1884393/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1884393</span></a>] [<a href="/pubmed/14651726" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14651726</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.bellomo.2010.865">Bellomo F, Corallini S, Pastore A, Palma A, Laurenzi C, Emma F, Taranta A. Modulation of CTNS gene expression by intracellular thiols. <span><span class="ref-journal">Free Radic Biol Med. </span>2010;<span class="ref-vol">48</span>:865–72.</span> [<a href="/pubmed/20079424" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20079424</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.besouw.2010a.787">Besouw MT, Hulstijn-Dirkmaat GM, van der Rijken RE, Cornelissen EA, van Dael CM, Vande Walle J, Lilien MR, Levtchenko EN. Neurocognitive functioning in school-aged cystinosis patients. <span><span class="ref-journal">J Inherit Metab Dis. </span>2010a;<span class="ref-vol">33</span>:787–93.</span> [<a href="/pmc/articles/PMC2992654/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2992654</span></a>] [<a href="/pubmed/20814825" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20814825</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.besouw.2010b.1880">Besouw MT, Kremer JA, Janssen MC, Levtchenko EN. Fertility status in male cystinosis patients treated with cysteamine. <span><span class="ref-journal">Fertil Steril. </span>2010b;<span class="ref-vol">93</span>:1880–3.</span> [<a href="/pubmed/19217094" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19217094</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.charnas.1991.1318">Charnas LR, Bernardini I, Rader D, Hoeg JM, Gahl WA. Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function. <span><span class="ref-journal">N Engl J Med. </span>1991;<span class="ref-vol">324</span>:1318–25.</span> [<a href="/pubmed/2017228" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2017228</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.charnas.1994.181">Charnas LR, Luciano CA, Dalakas M, Gilliatt RW, Bernardini I, Ishak K, Cwik VA, Fraker D, Brushart TA, Gahl WA. Distal vacuolar myopathy in nephropathic cystinosis. <span><span class="ref-journal">Ann Neurol. </span>1994;<span class="ref-vol">35</span>:181–8.</span> [<a href="/pubmed/8109899" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8109899</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.cherqui.2002.7622">Cherqui S, Sevin C, Hamard G, Kalatzis V, Sich M, Pequignot MO, Gogat K, Abitbol M, Broyer M, Gubler MC, Antignac C. Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis. <span><span class="ref-journal">Mol Cell Biol. </span>2002;<span class="ref-vol">22</span>:7622–32.</span> [<a href="/pmc/articles/PMC135682/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC135682</span></a>] [<a href="/pubmed/12370309" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12370309</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.chik.1993.568">Chik CL, Friedman A, Merriam GR, Gahl WA. Pituitary-testicular function in nephropathic cystinosis. <span><span class="ref-journal">Ann Intern Med. </span>1993;<span class="ref-vol">119</span>:568–75.</span> [<a href="/pubmed/8363167" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8363167</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.delgado.2005.403">Delgado G, Schatz A, Nichols S, Appelbaum M, Trauner D. Behavioral profiles of children with infantile nephropathic cystinosis. <span><span class="ref-journal">Dev Med Child Neurol. </span>2005;<span class="ref-vol">47</span>:403–7.</span> [<a href="/pubmed/15938069" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15938069</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.didomenico.2004.693">DiDomenico P, Berry G, Bass D, Fridge J, Sarwal M. Noncirrhotic portal hypertension in association with juvenile nephropathic cystinosis: case presentation and review of the literature. <span><span class="ref-journal">J Inherit Metab Dis. </span>2004;<span class="ref-vol">27</span>:693–9.</span> [<a href="/pubmed/15669688" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15669688</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.dogulu.2004.673">Dogulu CF, Tsilou E, Rubin B, Fitzgibbon EJ, Kaiser-Kupper MI, Rennert OM, Gahl WA. Idiopathic intracranial hypertension in cystinosis. <span><span class="ref-journal">J Pediatr. </span>2004;<span class="ref-vol">145</span>:673–8.</span> [<a href="/pubmed/15520772" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15520772</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.dohil.2003.224">Dohil R, Newbury RO, Sellers ZM, Deutsch R, Schneider JA. The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine. <span><span class="ref-journal">J Pediatr. </span>2003;<span class="ref-vol">143</span>:224–30.</span> [<a href="/pubmed/12970638" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12970638</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.freed.2011.563">Freed KA, Blangero J, Howard T, Johnson MP, Curran JE, Garcia YR, Lan HC, Abboud HE, Moses EK. The 57 kb deletion in cystinosis patients extends into TRPV1 causing dysregulation of transcription in peripheral blood mononuclear cells. <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:563–6.</span> [<a href="/pubmed/21546516" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21546516</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.gahl.2007.242">Gahl WA, Balog J, Kleta R. Nephropathic cystinosis in adults: natural history and effect of oral cysteamine therapy. <span><span class="ref-journal">Ann Intern Med. </span>2007;<span class="ref-vol">147</span>:242–50.</span> [<a href="/pubmed/17709758" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17709758</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.gahl.2000.100">Gahl WA, Kuehl EM, Iwata F, Lindblad A, Kaiser-Kupfer MI. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. <span><span class="ref-journal">Mol Genet Metab. </span>2000;<span class="ref-vol">71</span>:100–20.</span> [<a href="/pubmed/11001803" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11001803</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.gahl.2002.111">Gahl WA, Thoene JG, Schneider JA. Cystinosis. <span><span class="ref-journal">N Engl J Med. </span>2002;<span class="ref-vol">347</span>:111–21.</span> [<a href="/pubmed/12110740" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12110740</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.gahl.2001">Gahl WA, Thoene JG, Schneider JA. Cystinosis: A disorder of lysosomal membrane transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, eds. <em>The Metabolic and Molecular Bases of Inherited Disease</em>. 8 ed. New York, NY: McGraw-Hill; 2001:5085-108.</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.haase.2006.677">Haase M, Morgera S, Bamberg C, Halle H, Martini S, Dragun D, Neumayer H-H, Budde K. Successful pregnancies in dialysis patients including those suffering from cystinosis and familial Mediterranean fever. <span><span class="ref-journal">J Nephrol. </span>2006;<span class="ref-vol">19</span>:677–81.</span> [<a href="/pubmed/17136701" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17136701</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.ivanova.2016.1037">Ivanova EA, Arcolino FO, Elmonem MA, Rastaldi MP, Giardino L, Cornelissen EM, van den Heuvel LP, Levtchenko EN. Cystinosin deficiency causes podocyte damage and loss associated with increased cell motility. <span><span class="ref-journal">Kidney Int. </span>2016;<span class="ref-vol">89</span>:1037–48.</span> [<a href="/pubmed/27083281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27083281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.ivanova.2015.e0120998">Ivanova EA, De Leo MG, Van Den Heuvel L, Pastore A, Dijkman H, De Matteis MA, Levtchenko EN. Endo-lysosomal dysfunction in human proximal tubular epithelial cells deficient for lysosomal cystine transporter cystinosin. <span><span class="ref-journal">PLoS One. </span>2015;<span class="ref-vol">10</span>:e0120998.</span> [<a href="/pmc/articles/PMC4374958/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4374958</span></a>] [<a href="/pubmed/25811383" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25811383</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.kaiserkupfer.1987.775">Kaiser-Kupfer MI, Fujikawa L, Kuwabara T, Jain S, Gahl WA. Removal of corneal crystals by topical cysteamine in nephropathic cystinosis. <span><span class="ref-journal">N Engl J Med. </span>1987;<span class="ref-vol">316</span>:775–9.</span> [<a href="/pubmed/3821824" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3821824</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.kalatzis.2002.1883">Kalatzis V, Antignac C. Cystinosis: from gene to disease. <span><span class="ref-journal">Nephrol Dial Transplant. </span>2002;<span class="ref-vol">17</span>:1883–6.</span> [<a href="/pubmed/12401840" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12401840</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.kalatzis.2003.207">Kalatzis V, Antignac C. New aspects of the pathogenesis of cystinosis. <span><span class="ref-journal">Pediatr Nephrol. </span>2003;<span class="ref-vol">18</span>:207–15.</span> [<a href="/pubmed/12644911" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12644911</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.kalatzis.2002.439">Kalatzis V, Cohen-Solal L, Cordier B, Frishberg Y, Kemper M, Nuutinen EM, Legrand E, Cochat P, Antignac C. Identification of 14 novel CTNS mutations and characterization of seven splice site mutations associated with cystinosis. <span><span class="ref-journal">Hum Mutat. </span>2002;<span class="ref-vol">20</span>:439–46.</span> [<a href="/pubmed/12442267" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12442267</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.kiehntopf.2002.237">Kiehntopf M, Schickel J, Gonne B, Koch HG, Superti-Furga A, Steinmann B, Deufel T, Harms E. Analysis of the CTNS gene in patients of German and Swiss origin with nephropathic cystinosis. <span><span class="ref-journal">Hum Mutat. </span>2002;<span class="ref-vol">20</span>:237.</span> [<a href="/pubmed/12204010" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12204010</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.kleta.2006.718">Kleta R. A deeper look into cysteamine absorption for the treatment of cystinosis. <span><span class="ref-journal">J Pediatr. </span>2006;<span class="ref-vol">148</span>:718–9.</span> [<a href="/pubmed/16769374" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16769374</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.kleta.2001.332">Kleta R, Anikster Y, Lucero C, Shotelersuk V, Huizing M, Bernardini I, Park M, Thoene J, Schneider J, Gahl WA. CTNS mutations in African American patients with cystinosis. <span><span class="ref-journal">Mol Genet Metab. </span>2001;<span class="ref-vol">74</span>:332–7.</span> [<a href="/pubmed/11708862" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11708862</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.kleta.2004a.555">Kleta R, Bernardini I, Ueda M, Varade WS, Phornphutkul C, Krasnewich D, Gahl WA. Long-term follow-up of well-treated nephropathic cystinosis patients. <span><span class="ref-journal">J Pediatr. </span>2004a;<span class="ref-vol">145</span>:555–60.</span> [<a href="/pubmed/15480385" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15480385</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.kleta.2004b.410">Kleta R, Blair SC, Bernardini I, Kaiser-Kupfer MI, Gahl WA. Keratopathy of multiple myeloma masquerading as corneal crystals of ocular cystinosis. <span><span class="ref-journal">Mayo Clin Proc. </span>2004b;<span class="ref-vol">79</span>:410–2.</span> [<a href="/pubmed/15008615" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15008615</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.kleta.2002.2189">Kleta R, Gahl WA. Cystinosis: antibodies and healthy bodies. <span><span class="ref-journal">J Am Soc Nephrol. </span>2002;<span class="ref-vol">13</span>:2189–91.</span> [<a href="/pubmed/12138155" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12138155</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.kleta.2004.2255">Kleta R, Gahl WA. Pharmacological treatment of nephropathic cystinosis with cysteamine. <span><span class="ref-journal">Expert Opin Pharmacother. </span>2004;<span class="ref-vol">5</span>:2255–62.</span> [<a href="/pubmed/15500372" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15500372</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.kleta.2005.452">Kleta R, Kaskel F, Dohil R, Goodyer P, Guay-Woodford LM, Harms E, Ingelfinger JR, Koch VH, Langman CB, Leonard MB, Mannon RB, Sarwal M, Schneider JA, Skovby F, Sonies BC, Thoene JG, Trauner DA, Gahl WA. First NIH/Office of Rare Diseases Conference on Cystinosis: past, present, and future. <span><span class="ref-journal">Pediatr Nephrol. </span>2005;<span class="ref-vol">20</span>:452–4.</span> [<a href="/pubmed/15747161" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15747161</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.langman.2012.1112">Langman CB, Greenbaum LA, Sarwal M, Grimm P, Niaudet P, Desch&#x000ea;nes G, Cornelissen E, Morin D, Cochat P, Matossian D, Gaillard S, Bagger MJ, Rioux P. A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety. <span><span class="ref-journal">Clin J Am Soc Nephrol. </span>2012;<span class="ref-vol">7</span>:1112–20.</span> [<a href="/pmc/articles/PMC3386675/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3386675</span></a>] [<a href="/pubmed/22554716" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22554716</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.larsen.2010.417">Larsen CP, Walker PD, Thoene JG. The incidence of atubular glomeruli in nephropathic cystinosis renal biopsies. <span><span class="ref-journal">Mol Genet Metab. </span>2010;<span class="ref-vol">101</span>:417–20.</span> [<a href="/pubmed/20826102" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20826102</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.mac_asvidal.2009.486">Mac&#x000ed;as-Vidal J, Rod&#x000e9;s M, Hern&#x000e1;ndez-P&#x000e9;rez JM, Vilaseca MA, Coll MJ. Analysis of the CTNS gene in 32 cystinosis patients from Spain. <span><span class="ref-journal">Clin Genet. </span>2009;<span class="ref-vol">76</span>:486–9.</span> [<a href="/pubmed/19863563" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19863563</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.mahoney.2000.50">Mahoney CP, Striker GE. Early development of the renal lesions in infantile cystinosis. <span><span class="ref-journal">Pediatr Nephrol. </span>2000;<span class="ref-vol">15</span>:50–6.</span> [<a href="/pubmed/11095011" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11095011</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.markello.1993.1157">Markello TC, Bernardini IM, Gahl WA. Improved renal function in children with cystinosis treated with cysteamine. <span><span class="ref-journal">N Engl J Med. </span>1993;<span class="ref-vol">328</span>:1157–62.</span> [<a href="/pubmed/8455682" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8455682</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.mason.2003.503">Mason S, Pepe G, Dall'Amico R, Tartaglia S, Casciani S, Greco M, Bencivenga P, Murer L, Rizzoni G, Tenconi R, Clementi M. Mutational spectrum of the CTNS gene in Italy. <span><span class="ref-journal">Eur J Hum Genet. </span>2003;<span class="ref-vol">11</span>:503–8.</span> [<a href="/pubmed/12825071" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12825071</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.mcgowanjordan.1999.671">McGowan-Jordan J, Stoddard K, Podolsky L, Orrbine E, McLaine P, Town M, Goodyer P, MacKenzie A, Heick H. Molecular analysis of cystinosis: probable Irish origin of the most common French Canadian mutation. <span><span class="ref-journal">Eur J Hum Genet. </span>1999;<span class="ref-vol">7</span>:671–8.</span> [<a href="/pubmed/10482956" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10482956</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.middleton.2003.2492">Middleton R, Bradbury M, Webb N, O&#x02019;Donoghue D, Van&#x02019;t Hoff W. Cystinosis. A clinicopathological conference. "From toddlers to twenties and beyond" Adult-Paediatric Nephrology Interface Meeting, Manchester 2001. <span><span class="ref-journal">Nephrol Dial Transplant. </span>2003;<span class="ref-vol">18</span>:2492–5.</span> [<a href="/pubmed/14605270" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14605270</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.nesterova.2008.863">Nesterova G, Gahl W. Nephropathic cystinosis: late complications of a multisystemic disease. <span><span class="ref-journal">Pediatr Nephrol. </span>2008;<span class="ref-vol">23</span>:863–78.</span> [<a href="/pubmed/18008091" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18008091</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.nesterova.2015.945">Nesterova G, Williams C, Bernardini I, Gahl WA. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy. <span><span class="ref-journal">Pediatr Nephrol. </span>2015;<span class="ref-vol">30</span>:945–51.</span> [<a href="/pubmed/25526929" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25526929</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.o_brien.2006.387">O&#x02019;Brien K, Hussain N, Warady BA, Kleiner DE, Kleta R, Bernardini I, Heller T, Gahl WA. Nodular regenerative hyperplasia and severe portal hypertension in cystinosis. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2006;<span class="ref-vol">4</span>:387–94.</span> [<a href="/pubmed/16527704" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16527704</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.osefo.2009.433">Osefo N, Ito T, Jensen RT. Gastric acid hypersecretory states: recent insights and advances. <span><span class="ref-journal">Curr Gastroenterol Rep. </span>2009;<span class="ref-vol">11</span>:433–41.</span> [<a href="/pmc/articles/PMC2792981/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2792981</span></a>] [<a href="/pubmed/19903418" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19903418</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.park.2002.2878">Park M, Helip-Wooley A, Thoene J. Lysosomal cystine storage augments apoptosis in cultured human fibroblasts and renal tubular epithelial cells. <span><span class="ref-journal">J Am Soc Nephrol. </span>2002;<span class="ref-vol">13</span>:2878–87.</span> [<a href="/pubmed/12444206" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12444206</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.phornphutkul.2001.712">Phornphutkul C, Anikster Y, Huizing M, Braun P, Brodie C, Chou JY, Gahl WA. The promoter of a lysosomal membrane transporter gene, CTNS, binds Sp-1, shares sequences with the promoter of an adjacent gene, CARKL, and causes cystinosis if mutated in a critical region. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">69</span>:712–21.</span> [<a href="/pmc/articles/PMC1226058/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1226058</span></a>] [<a href="/pubmed/11505338" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11505338</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.ramappa.2010.220">Ramappa AJ, Pyatt JR. Pregnancy-associated cardiomyopathy occurring in a young patient with nephropathic cystinosis. <span><span class="ref-journal">Cardiol Young. </span>2010;<span class="ref-vol">20</span>:220–2.</span> [<a href="/pubmed/20199711" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20199711</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.sansanwal.2010.775">Sansanwal P, Li L, Hsieh SC, Sarwal MM. Insights into novel cellular injury mechanisms by gene expression profiling in nephropathic cystinosis. <span><span class="ref-journal">J Inherit Metab Dis. </span>2010;<span class="ref-vol">33</span>:775–86.</span> [<a href="/pubmed/20865335" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20865335</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.schneider.2004.436">Schneider JA. Treatment of cystinosis: simple in principle, difficult in practice. <span><span class="ref-journal">J Pediatr. </span>2004;<span class="ref-vol">145</span>:436–8.</span> [<a href="/pubmed/15480361" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15480361</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.servais.2008.27">Servais A, Morini&#x000e8;re V, Gr&#x000fc;nfeld JP, No&#x000eb;l LH, Goujon JM, Chadefaux-Vekemans B, Antignac C. Late-onset nephropathic cystinosis: clinical presentation, outcome, and genotyping. <span><span class="ref-journal">Clin J Am Soc Nephrol. </span>2008;<span class="ref-vol">3</span>:27–35.</span> [<a href="/pmc/articles/PMC2390982/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2390982</span></a>] [<a href="/pubmed/18178779" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18178779</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.shotelersuk.1998.1352">Shotelersuk V, Larson D, Anikster Y, McDowell G, Lemons R, Bernardini I, Guo J, Thoene J, Gahl WA. CTNS mutations in an American-based population of cystinosis patients. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">63</span>:1352–62.</span> [<a href="/pmc/articles/PMC1377545/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377545</span></a>] [<a href="/pubmed/9792862" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9792862</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.sonies.2005.137">Sonies BC, Almajid P, Kleta R, Bernardini I, Gahl WA. Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy. <span><span class="ref-journal">Medicine (Baltimore). </span>2005;<span class="ref-vol">84</span>:137–46.</span> [<a href="/pubmed/15879904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15879904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.spilkin.2007.444">Spilkin AM, Ballantyne AO, Babchuck LR, Trauner DA. Non-verbal deficits in young children with a genetic metabolic disorder: WPPSI-III performance in cystinosis. <span><span class="ref-journal">Am J Med Genet B Neuropsychiatr Genet. </span>2007;<span class="ref-vol">144B</span>:444–7.</span> [<a href="/pubmed/17471495" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17471495</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.thoene.1999.283">Thoene J, Lemons R, Anikster Y, Mullet J, Paelicke K, Lucero C, Gahl W, Schneider J, Shu SG, Campbell HT. Mutations of CTNS causing intermediate cystinosis. <span><span class="ref-journal">Mol Genet Metab. </span>1999;<span class="ref-vol">67</span>:283–93.</span> [<a href="/pubmed/10444339" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10444339</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.thoene.1995.380">Thoene JG. Cystinosis. <span><span class="ref-journal">J Inherit Metab Dis. </span>1995;<span class="ref-vol">18</span>:380–6.</span> [<a href="/pubmed/7494397" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7494397</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.touchman.2000.165">Touchman JW, Anikster Y, Dietrich NL, Maduro VV, McDowell G, Shotelersuk V, Bouffard GG, Beckstrom-Sternberg SM, Gahl WA, Green ED. The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion. <span><span class="ref-journal">Genome Res. </span>2000;<span class="ref-vol">10</span>:165–73.</span> [<a href="/pmc/articles/PMC310836/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC310836</span></a>] [<a href="/pubmed/10673275" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10673275</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.town.1998.319">Town M, Jean G, Cherqui S, Attard M, Forestier L, Whitmore SA, Callen DF, Gribouval O, Broyer M, Bates GP, van't Hoff W, Antignac C. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. <span><span class="ref-journal">Nat Genet. </span>1998;<span class="ref-vol">18</span>:319–24.</span> [<a href="/pubmed/9537412" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9537412</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.trauner.2001.365">Trauner DA, Fahmy RF, Mishler DA. Oral motor dysfunction and feeding difficulties in nephropathic cystinosis. <span><span class="ref-journal">Pediatr Neurol. </span>2001;<span class="ref-vol">24</span>:365–8.</span> [<a href="/pubmed/11516611" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11516611</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.tsilou.2007.97">Tsilou E, Zhou M, Gahl W, Sieving PC, Chan CC. Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature. <span><span class="ref-journal">Surv Ophthalmol. </span>2007;<span class="ref-vol">52</span>:97–105.</span> [<a href="/pmc/articles/PMC1850966/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1850966</span></a>] [<a href="/pubmed/17212992" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17212992</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.tsilou.2006.1002">Tsilou ET, Rubin BI, Reed G, Caruso RC, Iwata F, Balog J, Gahl WA, Kaiser-Kupfer MI. Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy. <span><span class="ref-journal">Ophthalmology. </span>2006;<span class="ref-vol">113</span>:1002–9.</span> [<a href="/pubmed/16603246" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16603246</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.tsilou.2002.173">Tsilou ET, Rubin BI, Reed GF, Iwata F, Gahl W, Kaiser-Kupfer MI. Age-related prevalence of anterior segment complications in patients with infantile nephropathic cystinosis. <span><span class="ref-journal">Cornea. </span>2002;<span class="ref-vol">21</span>:173–6.</span> [<a href="/pubmed/11862089" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11862089</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.ueda.2006.555">Ueda M, O&#x02019;Brien K, Rosing D, Ling A, Kleta R, McAreavey D, Bernardini I, Gahl W. Coronary artery and other vascular calcifications in patients with cystinosis after kidney transplantation. <span><span class="ref-journal">Clin J Am Soc Nephrol. </span>2006;<span class="ref-vol">1</span>:555–62.</span> [<a href="/pubmed/17699259" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17699259</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.veys.2018.1">Veys KR, D'Hauwers KW, van Dongen AJ, Janssen MC, Besouw MT, Goossens E, van den Heuvel LP, Wetzels AA, Levtchenko EN. First successful conception induced by a male cystinosis patient. <span><span class="ref-journal">JIMD Rep. </span>2018;<span class="ref-vol">38</span>:1–6.</span> [<a href="/pmc/articles/PMC5874217/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5874217</span></a>] [<a href="/pubmed/28405942" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28405942</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.wamelink.2011.339">Wamelink MM, Struys EA, Jansen EE, Blom HJ, Vilboux T, Gahl WA, K&#x000f6;mhoff M, Jakobs C, Levtchenko EN. Elevated concentrations of sedoheptulose in bloodspots of patients with cystinosis caused by the 57-kb deletion: implications for diagnostics and neonatal screening. <span><span class="ref-journal">Mol Genet Metab. </span>2011;<span class="ref-vol">102</span>:339–42.</span> [<a href="/pubmed/21195649" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21195649</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.wilmer.2010.f905">Wilmer MJ, Emma F, Levtchenko EN. The pathogenesis of cystinosis: mechanisms beyond cystine accumulation. <span><span class="ref-journal">Am J Physiol Renal Physiol. </span>2010;<span class="ref-vol">299</span>:F905–16.</span> [<a href="/pubmed/20826575" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20826575</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.wilmer.2011.643">Wilmer MJ, Kluijtmans LA, van der Velden TJ, Willems PH, Scheffer PG, Masereeuw R, Monnens LA, van den Heuvel LP, Levtchenko EN. Cysteamine restores glutathione redox status in cultured cystinotic proximal tubular epithelial cells. <span><span class="ref-journal">Biochim Biophys Acta. </span>2011;<span class="ref-vol">1812</span>:643–51.</span> [<a href="/pubmed/21371554" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21371554</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.w_hl.2001.880">W&#x000fc;hl E, Haffner D, Offner G, Broyer M, van't Hoff W, Mehls O, et al.  Long-term treatment with growth hormone in short children with nephropathic cystinosis. <span><span class="ref-journal">J Pediatr. </span>2001;<span class="ref-vol">138</span>:880–7.</span> [<a href="/pubmed/11391333" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11391333</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.yeagy.2011.1198">Yeagy BA, Harrison F, Gubler MC, Koziol JA, Salomon DR, Cherqui S. Kidney preservation by bone marrow cell transplantation in hereditary nephropathy. <span><span class="ref-journal">Kidney Int. </span>2011;<span class="ref-vol">79</span>:1198–206.</span> [<a href="/pubmed/21248718" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21248718</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ctns.REF.zimakas.2003.384">Zimakas PJ, Sharma AK, Rodd CJ. Osteopenia and fractures in cystinotic children post renal transplantation. <span><span class="ref-journal">Pediatr Nephrol. </span>2003;<span class="ref-vol">18</span>:384–90.</span> [<a href="/pubmed/12700967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12700967</span></a>]</div></li></ul></div></div><div id="ctns.Chapter_Notes"><h2 id="_ctns_Chapter_Notes_">Chapter Notes</h2><div id="ctns.Author_Notes"><h3>Author Notes</h3><p>Dr Gahl is a pediatrician, medical geneticist, and biochemical geneticist who performs clinical and basic research into rare diseases. He has seen approximately 300 individuals with cystinosis and published more than 85 articles and reviews on the subject.</p></div><div id="ctns.Author_History"><h3>Author History</h3><p>William A Gahl, MD, PhD (2001-present)<br />Robert Kleta, MD, PhD; National Human Genome Research Institute (2001-2009)<br />Galina Nesterova, MD (2009-present)</p></div><div id="ctns.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 December 2017 (ma) Revision: information from Veys et al 2017</div></li><li class="half_rhythm"><div>6 October 2016 (sw) Comprehensive upated posted live</div></li><li class="half_rhythm"><div>30 January 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>17 May 2012 (cd) Revision: to include <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> for identification of deletions/duplications in addition to the common 57-kb deletion</div></li><li class="half_rhythm"><div>11 August 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 April 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 October 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 June 2003 (ca) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 March 2001 (me) Review posted live</div></li><li class="half_rhythm"><div>January 2001 (wg) Original submission</div></li></ul><p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <i>GeneReview</i> "Cystinosis" is in the public <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> in the United States of America.</p></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1400</span><span class="label">PMID: <a href="/pubmed/20301574" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301574</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cf/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/abs/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1400&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1400/?report=reader">PubReader</a></li><li><a href="/books/NBK1400/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1400" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1400" style="display:none" title="Cite this Page"><div class="bk_tt">Nesterova G, Gahl WA. Cystinosis. 2001 Mar 22 [Updated 2017 Dec 7]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1400/pdf/Bookshelf_NBK1400.pdf">PDF version of this page</a> (1.0M)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ctns.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#ctns.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#ctns.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#ctns.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#ctns.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#ctns.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#ctns.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#ctns.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#ctns.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#ctns.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#ctns.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#ctns.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1497[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CTNS</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1400+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1484644" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1484644" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1484644" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1484644" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301489" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bali DS, Chen YT, Austin S, Goldstein JL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/14610675" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Early oral cysteamine therapy for nephropathic cystinosis.</a><span class="source">[Eur J Pediatr. 2003]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Early oral cysteamine therapy for nephropathic cystinosis.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gahl WA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Pediatr. 2003 Dec; 162 Suppl 1:S38-41. Epub 2003 Nov 11.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301688" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Tyrosinemia Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Tyrosinemia Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sniderman King L, Trahms C, Scott CR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/11001803" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.</a><span class="source">[Mol Genet Metab. 2000]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gahl WA, Kuehl EM, Iwata F, Lindblad A, Kaiser-Kupfer MI. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Mol Genet Metab. 2000 Sep-Oct; 71(1-2):100-20. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301444" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alström Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alström Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Paisey RB, Steeds R, Barrett T, Williams D, Geberhiwot T, Gunay-Aygun M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301574" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301574" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0411a7dd21425a25a6c384">Cystinosis - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Cystinosis - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:49:28-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE893893E040873100000000048A01E9&amp;ncbi_session=CE893893E0411A71_1162SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1400%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1400&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1400/&amp;ncbi_pagename=Cystinosis - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE893893E0411A71_1162SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>